NCT01024920 2021-07-19Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.Boehringer IngelheimPhase 2 Completed99 enrolled 45 charts
NCT02835833 2018-07-10Study of Nintedanib Plus Bevacizumab in Advanced Solid TumorsUniversity of Alabama at BirminghamPhase 1 Completed21 enrolled